Timber Pharmaceuticals, Inc. (NASDAQ:TMBR)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $0.94, but opened at $1.30. Timber Pharmaceuticals shares last traded at $1.19, with a volume of 257,602 shares trading hands.
The firm’s 50-day moving average is $0.94.
Timber Pharmaceuticals (NASDAQ:TMBR) last released its earnings results on Thursday, November 12th. The company reported $0.14 earnings per share for the quarter. The company had revenue of $0.33 million for the quarter.
Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.
Featured Story: Analyzing a company’s cash flow statement
Receive News & Ratings for Timber Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Timber Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.